en.Wedoany.com Reported - PodoPrinter parent company Qwadra has entered into an exclusive licensing agreement with BEGO Medical GmbH, covering a patent for 3D conveyor belt printing technology used in the continuous manufacturing of foot orthotics.

The agreement grants Qwadra exclusive rights to commercially develop 3D conveyor belt printers for insole production in European and international markets. Qwadra has been selling such devices under the PodoPrinter brand to orthopedists, podiatrists, and orthotic laboratories for several years.

The 3D conveyor belt printer replaces a fixed print platform with a continuously moving inclined conveyor belt, enabling sequential printing and automatic ejection of parts without downtime. In orthotic insole manufacturing, this architecture achieves continuous production efficiency that standard desktop 3D printers struggle to match.

BEGO Medical's license specifically targets conveyor belt printing configurations applied to orthotic insoles. While this market is a niche segment, it holds significant commercial value, with dimensional accuracy and material consistency being stringent clinical requirements.

Qwadra CEO Luc Boronat stated that this agreement recognizes the quality of the team's work and allows the company to invest in innovation, services, and international business expansion with clearer expectations.

Over the past decade, the foot orthotics market has become a significant application for additive manufacturing, driven by high customization demands and relatively simple geometric shapes. Current mainstream processes often use selective laser sintering (SLS) or Multi Jet Fusion based on PA11 or PA12 powders. Conveyor belt-based fused filament fabrication (FFF) offers an attractive entry point for medium-volume orthotic labs, with lower equipment costs and continuous production capabilities.

With the BEGO Medical license in place, Qwadra has built a defensible intellectual property barrier around this specific technical configuration. This provides a foundation for Qwadra to invest in commercial expansion without fear of competitors directly replicating its conveyor belt printing process for insole production.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com